← Leaderboards
Jyoti S Mathad
Weill Medical Coll Of Cornell Univ
$5,324,297
Attributed
$7,035,609
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,035,609 · 5
By mechanism
R01$4,724,691 · 2
K23$1,038,900 · 1
R25$790,316 · 1
R21$481,702 · 1
Top collaborators
- Radhika Lu Sundararajan5 shared
- Irina Burd2 shared
- Jennifer Alzos Downs2 shared
- Margaret Leighton Mcnairy2 shared
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Roy M Gulick$56,577,103
- Jennifer Alzos Downs$5,092,983
- Margaret Leighton McNairy$7,353,073
- Shashi Kapadia$4,528,330
- Sasha Fahme$555,660
Others in their field
Other Emerging Leaders on “Woman”
- Chanza Baytop · Westat, Inc.$271,217,917
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$29,616,650
- Abraham Aizer Brody · New York University School Of Medicine$16,015,961
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$14,031,836
- Michael P Harms · Washington University$13,645,932
- Jorge Eduardo Chavarro · Harvard School Of Public Health$12,830,103
Research focus
WomanPregnant WomenIndiaWomen&AposHigh RiskPostpartum PeriodPreventionPregnancyUnited States National Institutes Of HealthPreventFundingDiagnosisHigh Risk WomanMortalityIncidenceImmuneImmune ResponseCohortHomeLifeScreeningTrainingCountryCellular Immunity
Grant awards (18)
HIV, gestational diabetes and TB in pregnancy$665,122
R01 · FY2025 · AI · contact PI
A type 2 hybrid effectiveness-implementation trial of Community Health Workers to improve screening for postpartum diabetes in urban slums of India$434,990
R01 · FY2025 · HD
Developing Research Leadership in Infectious Diseases Impacting Women$411,412
R25 · FY2025 · AI
A type 2 hybrid effectiveness-implementation trial of Community Health Workers to improve screening for postpartum diabetes in urban slums of India$124,026
R01 · FY2025 · HD
A type 2 hybrid effectiveness-implementation trial of Community Health Workers to improve screening for postpartum diabetes in urban slums of India$63,205
R01 · FY2025 · HD
HIV, gestational diabetes and TB in pregnancy$687,723
R01 · FY2024 · AI · contact PI
A type 2 hybrid effectiveness-implementation trial of Community Health Workers to improve screening for postpartum diabetes in urban slums of India$606,840
R01 · FY2024 · HD
Developing Research Leaders in Global Infectious Diseases in Women$378,904
R25 · FY2024 · AI
HIV, gestational diabetes and TB in pregnancy$710,775
R01 · FY2023 · AI · contact PI
A type 2 hybrid effectiveness-implementation trial of Community Health Workers to improve screening for postpartum diabetes in urban slums of India$658,107
R01 · FY2023 · HD
HIV, gestational diabetes and TB in pregnancy$773,903
R01 · FY2022 · AI · contact PI
Effect of pregnancy and HIV on the development of tuberculosis$192,780
K23 · FY2021 · AI · contact PI
Effect of pregnancy and HIV on the development of tuberculosis$267,780
K23 · FY2020 · AI · contact PI
Placental determinants of neonatal immune function in maternal HIV infection$212,510
R21 · FY2020 · HD · contact PI
Placental determinants of neonatal immune function in maternal HIV infection$269,192
R21 · FY2019 · HD · contact PI
Effect of pregnancy and HIV on the development of tuberculosis$192,780
K23 · FY2019 · AI · contact PI
Effect of pregnancy and HIV on the development of tuberculosis$192,780
K23 · FY2018 · AI · contact PI
Effect of pregnancy and HIV on the development of tuberculosis$192,780
K23 · FY2017 · AI · contact PI